Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  The Yield Growth Corp.    BOSS   CA98584W2067

THE YIELD GROWTH CORP.

(BOSS)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Yield Growth Receives Health Canada Notification Numbers for 23 Plant-Based Products

share with twitter share with LinkedIn share with facebook
06/25/2020 | 06:05am EDT

Vancouver, British Columbia--(Newsfile Corp. - June 25, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) ("Yield Growth") is pleased to announce it has received 23 new cosmetic notification ("CN") numbers from Health Canada for its proprietary plant-based products to be launched under various brand collections.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/58537_yg1.jpg


Image 1: Yield Growth Receives Health Canada Notification Numbers for 23 Plant-Based Products

To view an enhanced version of Image 1, please visit:
https://orders.newsfilecorp.com/files/6377/58537_yg.jpg

Yield Growth submitted products across a variety of cosmetic categories for notification to Health Canada in March. On June 24, 2020, Yield Growth received confirmation that Health Canada acknowledged and approved its submissions and provided CN numbers for the following 23 plant-based products:

  • Eye Cream

  • Face & Eye Cleanser

  • Face & Body Mist

  • Nail Cuticle Oil

  • Deodorants (2 products)

  • Shaving Cream

  • Beard Oils (2 products)

  • Scented Roll-Ons (8 products)

  • Perfume Roll-Ons (6 products)

Yield Growth was founded on the belief that there had to be a better way - a philosophy of creating natural, plant-based products that work to improve health and wellness. Today, its brands, its products, and its people are all driven by the desire to play a role in enhancing people’s lives. Yield Growth selects plant-based, high-efficacy ingredients to offer products at accessible price points.

"We believe there is increasing value being placed by consumers on high-quality, plant-based, small-batch products that are responsibly made," says Yield Growth CEO Penny White. "Leveraging the expertise we have gained developing our extensive catalogue of proprietary plant-based product formulations, we believe we are well positioned to capitalize on this opportunity in the marketplace."

"Your skin is an indicator of what's going on inside your body," says Bhavna Solecki, Head of Product Development at Yield Growth. "Our mission is to restore the physical and emotional wellbeing of individuals with our pure, all-natural, and environmentally friendly wellness solutions."

Consumers today are increasingly concerned about the potential negative side effects for individuals and the environment of chemicals and animal-based ingredients in cosmetics and other products. According to a 2018 report by Grand View Research, Inc., “the global vegan cosmetics market size is projected to reach USD $20.8 billion by 2025, progressing at a CAGR of 6.3% during the forecast period...consumers embracing natural substitutes such as plant-based personal care products is working in favor of the market.”

About The Yield Growth Corp.

The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) is a phytoceutical and consumer packaged goods company that develops and acquires intellectual property and other assets related to plant-based products and therapeutics, and develops, manufactures, markets, sells and distributes plant-based products that improve lives. It has over 200 proprietary wellness formulas at various stages of commercialization, including over 20 products that are now for sale through e-commerce or brick and mortar retail stores. It is currently launching several hand sanitizer products in response to COVID-19. It has 14 patent applications filed in what the Global Wellness Institute reports is a $4.2 trillion-dollar global wellness market. Its majority owned subsidiary NeonMind Biosciences Inc. is launching a line of medicinal mushroom products and is developing intellectual property in the emerging area of psychedelic medicine. The Yield Growth management team has deep experience with global brands including Johnson & Johnson, Procter & Gamble, Skechers and Aritzia.

Investor Relations Contacts:

Penny White, President & CEO

Kevan Matheson, Investor Relations

invest@yieldgrowth.com

1-833-514-BOSS 1-833-514-2677

1-833-515-BOSS 1-833-515-2677

The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, "forward looking statements") under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, brand development, availability of packaging, intellectual property protection, reduced global commerce and reduced access to raw materials and other supplies do to the spread of the Coronavirus, the potential for not acquiring any rights as a result of the patent application and any products making use of the intellectual property may be ineffective or the company may be unsuccessful in commercializing them; and other approvals will be required before commercial exploitation of the intellectual property can happen. Demand for the company's products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/58537


© Newsfilecorp 2020
share with twitter share with LinkedIn share with facebook
Latest news on THE YIELD GROWTH CORP.
07/02Three Ex-U.S. and Canada Cannabis Stocks to Consider for Your Portfolio -- CF..
NE
07/02This May be the Trick to Treating a Massive $16 Billion Weight Issue
NE
06/29YIELD GROWTH : Reports Voting Results of its 2020 Annual General Meeting
AQ
06/25Yield Growth Receives Health Canada Notification Numbers for 23 Plant-Based P..
NE
06/24Yield Growth Announces Financing
NE
06/24The Future of Mental Health Will be Led by Psychedelics
NE
06/23Yield Growth Announces New Canadian Distributor for its Urban Juve Products
NE
06/19These Psychedelic Drugs May Be Key to Revolutionizing Weight Loss Treatment
NE
06/18NeonMind Files Patent Application for Therapeutic Use of DMT
NE
06/17Much Like Cannabis, Support for Psilocybin Legalization is Gaining Support in..
NE
More news
Financials
Sales 2019 4,02 M 2,96 M 2,96 M
Net income 2019 -16,0 M -11,8 M -11,8 M
Net cash 2019 0,54 M 0,40 M 0,40 M
P/E ratio 2019 -1,43x
Yield 2019 -
Capitalization 14,3 M 10,5 M 10,5 M
EV / Sales 2018 -
EV / Sales 2019 6,43x
Nbr of Employees 19
Free-Float 67,2%
Chart THE YIELD GROWTH CORP.
Duration : Period :
The Yield Growth Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THE YIELD GROWTH CORP.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 0,45 CAD
Last Close Price 0,10 CAD
Spread / Highest target 350%
Spread / Average Target 350%
Spread / Lowest Target 350%
EPS Revisions
Managers
NameTitle
Penny White President, Chief Executive Officer & Director
Tamara Melck Chief Operating Officer
Yu Cai Huang Chief Financial Officer
Spiros Margaris Independent Director
Amy Frankel Secretary, VP-People & General Counsel
Sector and Competitors
1st jan.Capitalization (M$)
THE YIELD GROWTH CORP.-47.37%11
JOHNSON & JOHNSON-3.36%371 399
ROCHE HOLDING AG4.71%295 898
MERCK & CO., INC.-13.38%198 849
NOVARTIS AG-10.36%192 057
PFIZER, INC.-11.92%191 697